Laboratory Products
Latest Robotic Technology for Automated Inhaler Tester
Jun 08 2009
Leading automation developer, Astech Projects, has announced the launch of its new fully automated Xelair® Series 5 system for automated inhaler testing. This system incorporates all existing features of the Xelair 1 and 3 series’ such as reduced variability, increased productivity and cost reduction. Additionally, the Xelair Series 5 includes the Device Handling and Storage (DHS) module with optional waste fire, which offers fully automated storage, handling and transfer of all devices. Therefore, the need for manual inhaler firing is eliminated, enabling the user to leave the system to operate unattended for up to 24 hours.
Utilising the latest robotic manipulator technology for increased throughput, robustness and flexibility, the Xelair Series 5 system offers an increased capacity for emitted dose collection. Furthermore, the ability to test up to 200 inhalers per day maximises testing in the minimal amount of time. This premium technology provides a fully automated solution for testing Dose Content Uniformity of the Emitted Dose, with each system and module designed to allow easy integration with each unique product.
Astech Projects’ Sales and Marketing Director, Anthony Moran, commented: “There is a real demand for increased throughput and consistent data within the pharmaceutical industry, a need which can be met with the Xelair systems. These products facilitate repeatable and reliable data, catering for changing client needs by allowing seamless migration between products in the Xelair range”.
Digital Edition
ILM 49.5 July
July 2024
Chromatography Articles - Understanding PFAS: Analysis and Implications Mass Spectrometry & Spectroscopy Articles - MS detection of Alzheimer’s blood-based biomarkers LIMS - Essent...
View all digital editions
Events
Jul 28 2024 San Diego, CA USA
Jul 30 2024 Jakarta, Indonesia
Jul 31 2024 Chengdu, China
ACS National Meeting - Fall 2024
Aug 18 2024 Denver, CO, USA
Aug 25 2024 Copenhagen, Denmark